Literature DB >> 10887087

Targeting of the EphA4 tyrosine kinase receptor affects dorsal/ventral pathfinding of limb motor axons.

F Helmbacher1, S Schneider-Maunoury, P Topilko, L Tiret, P Charnay.   

Abstract

The Eph family of tyrosine kinase receptors has recently been implicated in various processes involving the detection of environmental cues such as axonal guidance, targeted cell migration and boundary formation. We have inactivated the mouse EphA4 gene to investigate its functions during development. Homozygous EphA4 mutant animals show peroneal muscular atrophy correlating with the absence of the peroneal nerve, the main dorsal nerve of the hindlimb. This phenotype is also observed, although with a lower penetrance, in heterozygotes. During normal hindlimb innervation, motor axons converge towards the sciatic plexus region at the base of the limb bud, where they must choose between dorsal and ventral trajectories within the limb. Among the axons emerging from the sciatic plexus, dorsal projections show higher levels of EphA4 protein than ventral axons. In EphA4 mutant mice, presumptive dorsal motor axons fail to enter the dorsal compartment of the limb and join the ventral nerve. Our data therefore suggest that the level of EphA4 protein in growing limb motor axons is involved in the selection of dorsal versus ventral trajectories, thus contributing to the topographic organisation of motor projections.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10887087     DOI: 10.1242/dev.127.15.3313

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  69 in total

1.  Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred.

Authors:  Nicolas Prevost; Donna Woulfe; Takako Tanaka; Lawrence F Brass
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

Review 2.  Motor axon pathfinding.

Authors:  Dario Bonanomi; Samuel L Pfaff
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03       Impact factor: 10.005

Review 3.  Mechanisms of ephrin-Eph signalling in development, physiology and disease.

Authors:  Artur Kania; Rüdiger Klein
Journal:  Nat Rev Mol Cell Biol       Date:  2016-01-21       Impact factor: 94.444

4.  Concentration-dependent requirement for local protein synthesis in motor neuron subtype-specific response to axon guidance cues.

Authors:  Stéphane Nédelec; Mirza Peljto; Peng Shi; Mackenzie W Amoroso; Lance C Kam; Hynek Wichterle
Journal:  J Neurosci       Date:  2012-01-25       Impact factor: 6.167

5.  Eph tyrosine kinase receptor EphA4 is required for the topographic mapping of the corticospinal tract.

Authors:  Alison J Canty; Ursula Greferath; Ann M Turnley; Mark Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-09       Impact factor: 11.205

6.  HoxD cluster scanning deletions identify multiple defects leading to paralysis in the mouse mutant Ironside.

Authors:  Basile Tarchini; Thi Hanh Nguyen Huynh; Greg A Cox; Denis Duboule
Journal:  Genes Dev       Date:  2005-12-01       Impact factor: 11.361

7.  Genetic dissection of EphA receptor signaling dynamics during retinotopic mapping.

Authors:  Nicholas Bevins; Greg Lemke; Michaël Reber
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

8.  Generation of an EphA4 conditional allele in mice.

Authors:  Julia E Herrmann; Morgan A Pence; Emanuel A Shapera; Ravi R Shah; Cédric G Geoffroy; Binhai Zheng
Journal:  Genesis       Date:  2010-02       Impact factor: 2.487

9.  EphA4 is necessary for spatially selective peripheral somatosensory topography.

Authors:  H A North; A Karim; M F Jacquin; M J Donoghue
Journal:  Dev Dyn       Date:  2010-02       Impact factor: 3.780

10.  Coordinated actions of the forkhead protein Foxp1 and Hox proteins in the columnar organization of spinal motor neurons.

Authors:  David L Rousso; Zachary B Gaber; Deneen Wellik; Edward E Morrisey; Bennett G Novitch
Journal:  Neuron       Date:  2008-07-31       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.